CY1111811T1 - Μεθοδοι ms για την αξιολογηση γλυκανων - Google Patents

Μεθοδοι ms για την αξιολογηση γλυκανων

Info

Publication number
CY1111811T1
CY1111811T1 CY20111100864T CY111100864T CY1111811T1 CY 1111811 T1 CY1111811 T1 CY 1111811T1 CY 20111100864 T CY20111100864 T CY 20111100864T CY 111100864 T CY111100864 T CY 111100864T CY 1111811 T1 CY1111811 T1 CY 1111811T1
Authority
CY
Cyprus
Prior art keywords
methods
glucan
evaluation
glycans
things
Prior art date
Application number
CY20111100864T
Other languages
English (en)
Inventor
Carlos J Bosques
Nathaniel J Washburn
Xiangping Zhu
Ian Christopher Parsons
Original Assignee
Momenta Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Momenta Pharmaceuticals, Inc. filed Critical Momenta Pharmaceuticals, Inc.
Publication of CY1111811T1 publication Critical patent/CY1111811T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation

Abstract

Η παρούσα περιγραφή παρέχει, μεταξύ άλλων πραγμάτων, μεθόδους για την ανίχνευση θειικών γλυκανών σε ένα μείγμα γλυκανών.
CY20111100864T 2007-04-16 2011-09-08 Μεθοδοι ms για την αξιολογηση γλυκανων CY1111811T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92367707P 2007-04-16 2007-04-16
EP08745856A EP2135091B1 (en) 2007-04-16 2008-04-15 Ms methods to evaluate glycans

Publications (1)

Publication Number Publication Date
CY1111811T1 true CY1111811T1 (el) 2015-10-07

Family

ID=39615678

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100864T CY1111811T1 (el) 2007-04-16 2011-09-08 Μεθοδοι ms για την αξιολογηση γλυκανων

Country Status (14)

Country Link
US (1) US8043863B2 (el)
EP (1) EP2135091B1 (el)
JP (1) JP5116837B2 (el)
AT (1) ATE512366T1 (el)
AU (1) AU2008240074B2 (el)
CA (1) CA2682750A1 (el)
CY (1) CY1111811T1 (el)
DK (1) DK2135091T3 (el)
ES (1) ES2367210T3 (el)
HR (1) HRP20110610T1 (el)
PL (1) PL2135091T3 (el)
PT (1) PT2135091E (el)
SI (1) SI2135091T1 (el)
WO (1) WO2008128221A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2135091E (pt) 2007-04-16 2011-09-01 Momenta Pharmaceuticals Inc Métodos de ms para avaliar glicanos
WO2012149197A2 (en) 2011-04-27 2012-11-01 Abbott Laboratories Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US8956830B2 (en) 2013-03-14 2015-02-17 Momenta Pharmaceuticals, Inc. Methods of cell culture
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
US9217168B2 (en) 2013-03-14 2015-12-22 Momenta Pharmaceuticals, Inc. Methods of cell culture
US20160108450A1 (en) 2013-05-02 2016-04-21 Momenta Pharmaceutcals, Inc. Sialylated glycoproteins
EP2996772B1 (en) 2013-05-13 2018-12-19 Momenta Pharmaceuticals, Inc. Methods for the treatment of neurodegeneration
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
EP3058084A4 (en) 2013-10-16 2017-07-05 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
JP6471606B2 (ja) 2015-02-23 2019-02-20 Ａｇｃ株式会社 積層体の剥離装置及び剥離方法並びに電子デバイスの製造方法
US11719704B2 (en) 2015-12-30 2023-08-08 Momenta Pharmaceuticals, Inc. Methods related to biologics

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3383587B2 (ja) 1998-07-07 2003-03-04 株式会社東芝 静止画像連続情報記録方法と光ディスクと光ディスクの情報再生装置と情報再生方法
JP4828795B2 (ja) * 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
CA2510250A1 (en) * 2002-12-20 2004-08-12 Momenta Pharmaceuticals, Inc. Glycan markers for diagnosing and monitoring disease
WO2005009039A2 (en) * 2003-07-03 2005-01-27 Waters Investments Limited System and method for isotopic signature and mass analysis
US7138228B2 (en) 2003-09-05 2006-11-21 Regents Of The University Of California Protein O-sulfonation
US20060057638A1 (en) 2004-04-15 2006-03-16 Massachusetts Institute Of Technology Methods and products related to the improved analysis of carbohydrates
WO2006013925A1 (ja) * 2004-08-04 2006-02-09 Eisai R & D Management Co., Ltd. 同位体比によるペプチドを構成するアミノ酸配列の検定
JP2006047239A (ja) * 2004-08-09 2006-02-16 National Institute Of Advanced Industrial & Technology 硫酸化単糖の同定方法及び硫酸化単糖異性体混合物の分析方法
JP2009507212A (ja) * 2005-09-02 2009-02-19 オーストラリアン ヌークリア サイエンス アンド テクノロジー オーガニゼイション 同位体比質量分析計および同位体比の決定方法
PT2135091E (pt) 2007-04-16 2011-09-01 Momenta Pharmaceuticals Inc Métodos de ms para avaliar glicanos

Also Published As

Publication number Publication date
ES2367210T3 (es) 2011-10-31
AU2008240074A1 (en) 2008-10-23
US20100133430A1 (en) 2010-06-03
SI2135091T1 (sl) 2011-10-28
HRP20110610T1 (hr) 2011-10-31
PT2135091E (pt) 2011-09-01
JP5116837B2 (ja) 2013-01-09
CA2682750A1 (en) 2008-10-23
WO2008128221A1 (en) 2008-10-23
EP2135091B1 (en) 2011-06-08
US8043863B2 (en) 2011-10-25
AU2008240074B2 (en) 2013-02-21
JP2010525327A (ja) 2010-07-22
DK2135091T3 (da) 2011-09-19
EP2135091A1 (en) 2009-12-23
ATE512366T1 (de) 2011-06-15
PL2135091T3 (pl) 2011-11-30

Similar Documents

Publication Publication Date Title
CY1111811T1 (el) Μεθοδοι ms για την αξιολογηση γλυκανων
MX2010005888A (es) Anticuerpos bivalentes biespecificos.
UA100874C2 (en) Bivalent bispecific antibodies
MX2010005682A (es) Anticuerpos bivalentes, biespecificos.
CL2009001263S1 (es) Maquina de afeitar.
EA200702643A1 (ru) Антитела, связывающие tweak
RS53745B1 (en) 6-AMINO-2 - {[(1S) -1-METYLBUTIL] OKSI} -9- [5- (1-PIPERIDINIL) PENTIL] -7,9-DIHIDRO-8H-PURIN-8-ON-MALEAT
MY183144A (en) Toll-like receptor 3 antagonists
BR112014012590A8 (pt) Anticorpos anti-cd98 e métodos de uso dos mesmos
CL2007002182S1 (es) Terminal.
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
UA108199C2 (uk) АНТИТІЛО ПРОТИ α5β1 І ЙОГО ЗАСТОСУВАННЯ
CL2009001363S1 (es) Pieza para maquina de afeitar.
MX2011011623A (es) Antagonistas del receptor tipo toll 3.
BRPI0910383A2 (pt) compostos de poliuretano e/ou policarboanto de amônio
FR2940087B1 (fr) Erythrocytes contenant du facteur viii, preparation et utilisations.
EA201290804A1 (ru) Способ активации и сопряжения биомолекул
ECSP11011190A (es) Anticuerpos monoclonales anti-rhd
DE502008002979D1 (de) Arylsulfonamide mit analgetischer wirkung
TR200705450A2 (tr) Bir kişisel kimlik numarası belirleme yöntemi
ATE499138T1 (de) Implantierbare vorrichtung
CL2008000260S1 (es) Perfil.
CL2008000262S1 (es) Perfil.
CL2008000276S1 (es) Perfil.
CL2008000270S1 (es) Perfil.